Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Fixed-dose combination of albuterol and budesonide (PT027) demonstrated significant benefits for asthma patients in MANDALA and DENALI Phase III trials
-
AstraZeneca and European Commission reach settlement agreement over vaccine supply, ending litigation
-
Ultomiris approved in the EU for children and adolescents with paroxysmal nocturnal haemoglobinuria
-
AstraZeneca lung and breast cancer data at WCLC and ESMO 2021 underscore ambition to revolutionise outcomes for patients
-
Forxiga approved in Japan for the treatment of chronic kidney disease in patients with and without type-2 diabetes
-
ALXN1840 FoCus Phase III trial in Wilson disease met primary endpoint demonstrating improvement in copper mobilisation from tissues
-
Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotrophic lateral sclerosis
-
AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19
-
Update on US regulatory review of roxadustat in anaemia of chronic kidney disease
-
Forxiga approved in the EU for the treatment of chronic kidney disease in patients with and without type-2 diabetes
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
